The overall nephroprotective mechanism of AHWE and AHEE may, therefore, involve the inactivation of MAPK and NF-κB signaling pathways, highlighting a central regulatory mechanism in mitigating cisplatin-induced kidney damage. The gene discussed is NFKB1; the disease is Nephropathy.